Clinical trial · Interventional
Long-Term Follow-Up in Patients With Prostate Cancer After Surgery
Long-term Follow-up After Prostate Cancer
NCT03035500CI-TRIAL-00098961active not recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 9, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260909-000002
Summary
Brief summary (as posted)
This clinical trial studies how well a long-term follow-up works in patients with prostate cancer after surgery. Long-term follow-up data may serve as a resource to help ask clinical questions, describe health-related quality of life and long-term complications related, and facilitate future studies focusing on interventions to improve health status and health-related quality of life in prostate cancer survivors.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer Survivor | Prostate Neoplasm | PROBABILISTIC | 0.70 |
| Prostate Carcinoma | Prostate Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (5)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Educational Intervention | Other | — | UNRESOLVED |
| Laboratory Biomarker Analysis | Other | — | UNRESOLVED |
| Long-term Follow-up | Other | — | UNRESOLVED |
| Quality-of-Life Assessment | Other | — | UNRESOLVED |
| Questionnaire Administration | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Supportive Care (long-term follow-up)
- description
- Patients undergo long-term follow-up and receive a written survivorship care plan including comprehensive health evaluation and health education beginning 1 year post surgery.
- interventionNames
- Other: Educational Intervention
- Other: Laboratory Biomarker Analysis
- Other: Long-term Follow-up
- Other: Quality-of-Life Assessment
- Other: Questionnaire Administration
Primary outcomes (3)
- measure
- HRQL assessed using Expanded Prostate Cancer Index Composite
- timeFrame
- Up to 10 years
- description
- Linear mixed effects models can be used to estimate long-term trends and examine the effects of baseline and concomitant factors on these trends.
- measure
Eligibility
Eligibility (as posted)
- Sex
- Male
Show eligibility criteria text
Inclusion Criteria: * Diagnosis of prostate cancer * Treated with a definitive surgical procedure at City of Hope * At least one year post surgical treatment for prostate cancer * No history of recurrent, progressive, or metastatic disease * Currently stable disease or no evidence of disease * No prior treatment of prostate cancer with radiation or chemotherapy * No history of other urologic cancer (e.g., bladder cancer, renal cell carcinoma) in addition to prostate cancer * Note: Patients who develop recurrence while participating in the Prostate Cancer Survivorship Clinic will be referred back to their urologist and may resume participation in the Survivorship Clinic when deemed appropriate by their treating physician Exclusion Criteria: * Current treatment with testosterone replacement or androgen deprivation therapy * Treatment for another noncutaneous cancer within the past 2 years
References
Publications (0)
Data not yet available
No reference posted for this study.